Barclays Upgrades Abbott, Sees 'Selling Overdone' By: Benzinga via Benzinga October 07, 2015 at 08:28 AM EDT Shares of Abbott Laboratories (NYSE: ABT) have declined 19.8 percent over the last three months, hitting a low of $39.06 on ... Read More >> Related Stocks: Abbott Laboratories